Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.

TP-MBC had a worse survival than TP-FBC, and there were different genomic features between two groups. Current knowledge and treatment to TP-MBC maybe inadequate and remain to be explored.